HomeCompareMITPF vs PLD

MITPF vs PLD: Dividend Comparison 2026

MITPF yields 8.37% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.47M in total portfolio value· pulled ahead in Year 3
10 years
MITPF
MITPF
● Live price
8.37%
Share price
$23.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.8K
Annual income
$1,420.12
Full MITPF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — MITPF vs PLD

📍 PLD pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMITPFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MITPF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MITPF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MITPF
Annual income on $10K today (after 15% tax)
$711.30/yr
After 10yr DRIP, annual income (after tax)
$1,207.10/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,466,763.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MITPF + PLD for your $10,000?

MITPF: 50%PLD: 50%
100% PLD50/50100% MITPF
Portfolio after 10yr
$3.27M
Annual income
$2,628,928.15/yr
Blended yield
80.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MITPF
No analyst data
Altman Z
-1.5
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MITPF buys
0
PLD buys
0
No recent congressional trades found for MITPF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMITPFPLD
Forward yield8.37%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$34.8K$6.50M
Annual income after 10y$1,420.12$5,256,436.18
Total dividends collected$11.3K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MITPF vs PLD ($10,000, DRIP)

YearMITPF PortfolioMITPF Income/yrPLD PortfolioPLD Income/yrGap
1$11,537$836.82$11,255$555.24+$282.00MITPF
2$13,247$902.27$13,062$1,018.59+$185.00MITPF
3← crossover$15,142$968.21$15,903$1,926.67$761.00PLD
4$17,236$1,034.35$20,839$3,823.32$3.6KPLD
5$19,543$1,100.39$30,464$8,166.08$10.9KPLD
6$22,077$1,166.04$52,054$19,457.30$30.0KPLD
7$24,854$1,231.06$109,886$54,188.93$85.0KPLD
8$27,889$1,295.21$304,030$186,451.18$276.1KPLD
9$31,199$1,358.29$1,166,125$840,813.32$1.13MPLD
10$34,804$1,420.12$6,504,190$5,256,436.18$6.47MPLD

MITPF vs PLD: Complete Analysis 2026

MITPFStock

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.

Full MITPF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MITPF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MITPF vs SCHDMITPF vs JEPIMITPF vs OMITPF vs KOMITPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.